Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Role of peptidylarginine deiminase type 4 in gastric cancer.

Xin J, Song X.

Exp Ther Med. 2016 Nov;12(5):3155-3160.

2.

ΔNp63α expression induces loss of cell adhesion in triple-negative breast cancer cells.

Nekulova M, Holcakova J, Gu X, Hrabal V, Galtsidis S, Orzol P, Liu Y, Logotheti S, Zoumpourlis V, Nylander K, Coates PJ, Vojtesek B.

BMC Cancer. 2016 Oct 10;16(1):782.

3.

Shoc2-tranduced ERK1/2 motility signals--Novel insights from functional genomics.

Jeoung M, Jang ER, Liu J, Wang C, Rouchka EC, Li X, Galperin E.

Cell Signal. 2016 May;28(5):448-59. doi: 10.1016/j.cellsig.2016.02.005.

PMID:
26876614
4.

Multiple pathways regulate Cten in colorectal cancer without a Tensin switch.

Thorpe H, Akhlaq M, Jackson D, Al Ghamdi S, Storr S, Martin S, Ilyas M.

Int J Exp Pathol. 2015 Dec;96(6):362-9. doi: 10.1111/iep.12154.

5.

Tensin1 positively regulates RhoA activity through its interaction with DLC1.

Shih YP, Sun P, Wang A, Lo SH.

Biochim Biophys Acta. 2015 Dec;1853(12):3258-65. doi: 10.1016/j.bbamcr.2015.09.028.

6.

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression.

Kedmi M, Sas-Chen A, Yarden Y.

J Clin Med. 2015 Aug 13;4(8):1578-99. doi: 10.3390/jcm4081578. Review.

7.

A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration.

Cao X, Kaneko T, Li JS, Liu AD, Voss C, Li SS.

Nat Commun. 2015 Jul 13;6:7721. doi: 10.1038/ncomms8721. Erratum in: Nat Commun. 2015;6:8320.

8.
9.

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.

Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, Mancini M, Nataraj N, Kedmi M, Roth L, Köstler W, Zeisel A, Yitzhaky A, Zylberg J, Tarcic G, Eilam R, Wigelman Y, Will R, Lavi S, Porat Z, Wiemann S, Ricardo S, Schmitt F, Caldas C, Yarden Y.

EMBO Mol Med. 2015 Feb 12;7(3):299-314. doi: 10.15252/emmm.201404134.

10.

CDK5 is a major regulator of the tumor suppressor DLC1.

Tripathi BK, Qian X, Mertins P, Wang D, Papageorge AG, Carr SA, Lowy DR.

J Cell Biol. 2014 Dec 8;207(5):627-42. doi: 10.1083/jcb.201405105.

11.

C-terminal tensin-like protein mediates invasion of human lung cancer cells and is regulated by signal transducer and activator of transcription 3.

Bennett DT, Reece TB, Foley LS, Sjoberg A, Meng X, Fullerton DA, Weyant MJ.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):369-75. doi: 10.1016/j.jtcvs.2014.08.087.

12.

Heparanase cooperates with Ras to drive breast and skin tumorigenesis.

Boyango I, Barash U, Naroditsky I, Li JP, Hammond E, Ilan N, Vlodavsky I.

Cancer Res. 2014 Aug 15;74(16):4504-14. doi: 10.1158/0008-5472.CAN-13-2962.

13.

A mechanically-induced colon cancer cell population shows increased metastatic potential.

Tang X, Kuhlenschmidt TB, Li Q, Ali S, Lezmi S, Chen H, Pires-Alves M, Laegreid WW, Saif TA, Kuhlenschmidt MS.

Mol Cancer. 2014 May 29;13:131. doi: 10.1186/1476-4598-13-131.

14.

Steering tumor progression through the transcriptional response to growth factors and stroma.

Feldman ME, Yarden Y.

FEBS Lett. 2014 Aug 1;588(15):2407-14. doi: 10.1016/j.febslet.2014.05.036. Review.

15.

Tensin-4-dependent MET stabilization is essential for survival and proliferation in carcinoma cells.

Muharram G, Sahgal P, Korpela T, De Franceschi N, Kaukonen R, Clark K, Tulasne D, Carpén O, Ivaska J.

Dev Cell. 2014 May 27;29(4):421-36. doi: 10.1016/j.devcel.2014.03.024. Erratum in: Dev Cell. 2014 Jun 9:29(5):629-30.

16.

C-terminal tensin-like (CTEN): a promising biomarker and target for cancer.

Lo SH.

Int J Biochem Cell Biol. 2014 Jun;51:150-4. doi: 10.1016/j.biocel.2014.04.003. Review.

17.

Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.

Köstler WJ, Zeisel A, Körner C, Tsai JM, Jacob-Hirsch J, Ben-Chetrit N, Sharma K, Cohen-Dvashi H, Yitzhaky A, Lader E, Tschulena U, Rechavi G, Domany E, Wiemann S, Yarden Y.

PLoS One. 2013 Dec 6;8(12):e80566. doi: 10.1371/journal.pone.0080566.

18.

Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes.

Ludwig D, Carter J, Smith JR, Borsani G, Barlati S, Hafizi S.

BMC Med Genet. 2013 Jun 28;14:65. doi: 10.1186/1471-2350-14-65.

19.

CpG dinucleotide-specific hypermethylation of the TNS3 gene promoter in human renal cell carcinoma.

Carter JA, Górecki DC, Mein CA, Ljungberg B, Hafizi S.

Epigenetics. 2013 Jul;8(7):739-47. doi: 10.4161/epi.25075.

20.

CTEN prolongs signaling by EGFR through reducing its ligand-induced degradation.

Hong SY, Shih YP, Li T, Carraway KL 3rd, Lo SH.

Cancer Res. 2013 Aug 15;73(16):5266-76. doi: 10.1158/0008-5472.CAN-12-4441.

Items per page

Supplemental Content

Support Center